IP Library Patent Application 19594221
Patent Application Utility PCT National Stage
App. No. 19/594,221 · Confirmation No. 1710

ANTI-LILRB2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF CANCER

Inventor: Krystal Hamorsky
Application Undergoing Preexam Processing
⬇ PDF
Code Description Pages PDF
2026-08-17 A.PE Preliminary Amendment View
2026-08-17 A.PE Preliminary Amendment View
2026-08-17 SPEC Specification View
2026-08-17 REM Applicant Arguments/Remarks Made in an Amendment View
2026-08-17 N417 Electronic Filing System Acknowledgment Receipt View
2026-07-09 OATH Oath or Declaration filed View
2026-07-09 N417 Electronic Filing System Acknowledgment Receipt View
2026-06-05 TRAN.LET Transmittal Letter View
2026-06-05 PA.. Power of Attorney View
2026-06-05 OATH Oath or Declaration filed View
2026-06-05 371P Documents submitted with 371 (National Stage) Applications View
2026-06-05 371P Documents submitted with 371 (National Stage) Applications View
2026-06-05 371P Documents submitted with 371 (National Stage) Applications View
2026-06-05 N417.PYMT Electronic Fee Payment View
2026-06-05 ADS Application Data Sheet View
2026-06-05 N417 Electronic Filing System Acknowledgment Receipt View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
19/594,221
Effective Filing
2026-06-05